Hemopressin Peptide Reduces Pain and Inflammation in Experimental Arthritis
Hemopressin, a cannabinoid receptor inverse agonist peptide, reduced joint swelling, pain, and inflammation in a rat model of rheumatoid arthritis when given locally or orally.
Quick Facts
What This Study Found
Hemopressin reduced arthritis-induced joint swelling, pain behavior, and inflammatory markers (MPO, leukocytes, IL-6) via both intra-articular and oral routes, independent of CGRP and substance P.
Key Numbers
10-20 mcg/day i.art.; 20 mcg/kg oral; 4 days; reduced swelling, MPO, leukocytes, IL-6; SP and CGRP unchanged
How They Did This
Antigen-induced arthritis (AIA) in rats via intra-articular mBSA injection. Treatments: Hp (10/20 μg i.art. or 20 μg/kg oral) daily for 4 days. Measures: joint edema, gait analysis, leukocyte counts, cytokines, and spinal cord neuropeptide immunoreactivity.
Why This Research Matters
Rheumatoid arthritis affects millions and current treatments have significant side effects. A peptide targeting the endocannabinoid system that works both locally and orally could offer a novel therapeutic approach with a different safety profile.
The Bigger Picture
Endocannabinoid system modulation for arthritis is an active area of research. Hemopressin offers an intriguing approach as a peptide-based cannabinoid receptor modulator that avoids the psychoactive effects associated with cannabinoid agonists while still providing anti-inflammatory and pain-relieving benefits.
What This Study Doesn't Tell Us
Animal study — rat arthritis model may not fully represent human RA. Short 4-day treatment period. Small group sizes implied. Long-term safety and efficacy not assessed.
Questions This Raises
- ?Would hemopressin be effective in chronic arthritis models or human RA?
- ?What is the optimal route and dosing for clinical hemopressin use?
- ?How does hemopressin's anti-arthritic effect compare to existing biologics?
Trust & Context
- Key Stat:
- Effective by both local and oral routes Hemopressin reduced arthritis inflammation and pain comparable to indomethacin
- Evidence Grade:
- Well-designed preclinical study with multiple routes, doses, and outcome measures. Pre-clinical evidence requiring human translation.
- Study Age:
- Published in 2021, contributing to research on endocannabinoid system peptides for inflammatory conditions.
- Original Title:
- The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis.
- Published In:
- European journal of pharmacology, 890, 173636 (2021)
- Authors:
- Camargo, Livia L, Denadai-Souza, Alexandre, Yshii, Lidia M, Lima, Carla, Teixeira, Simone A, Cerqueira, Anderson R A, Gewehr, Mayara C F, Fernandes, Elizabeth S, Schenka, André A, Muscará, Marcelo N, Ferro, Emer S, Costa, Soraia K P
- Database ID:
- RPEP-05302
Evidence Hierarchy
Frequently Asked Questions
What is hemopressin and how does it relate to cannabis?
Hemopressin is a naturally occurring peptide in the body that modulates the same receptor system (endocannabinoid system) as cannabis compounds. Unlike THC, it acts as an inverse agonist — reducing the receptor's baseline activity — and doesn't cause psychoactive effects while still providing anti-inflammatory benefits.
Could hemopressin become a treatment for rheumatoid arthritis?
This study shows promise: hemopressin reduced joint swelling, improved mobility, and lowered inflammatory markers in arthritic rats, working through both injection and oral routes. However, it needs to be tested in human clinical trials before it could become a treatment option.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05302APA
Camargo, Livia L; Denadai-Souza, Alexandre; Yshii, Lidia M; Lima, Carla; Teixeira, Simone A; Cerqueira, Anderson R A; Gewehr, Mayara C F; Fernandes, Elizabeth S; Schenka, André A; Muscará, Marcelo N; Ferro, Emer S; Costa, Soraia K P. (2021). The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis.. European journal of pharmacology, 890, 173636. https://doi.org/10.1016/j.ejphar.2020.173636
MLA
Camargo, Livia L, et al. "The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis.." European journal of pharmacology, 2021. https://doi.org/10.1016/j.ejphar.2020.173636
RethinkPeptides
RethinkPeptides Research Database. "The potential anti-inflammatory and anti-nociceptive effects..." RPEP-05302. Retrieved from https://rethinkpeptides.com/research/camargo-2021-the-potential-antiinflammatory-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.